Investors focused on Dexcom’s lower gross margin of 61.3%, down about 170 basis points year-over-year, despite record revenue and earnings. The company said elevated scrap and freight costs would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback